Abbreviated New Drug Applications and following the path to generic drug approval. Generic drug applications are termed “abbreviated” because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness. Instead, generic applicants
Similar Posts
FDA Rationale for Recognition Decision: Isavuconazonium sulfate
FDA Rationale for Recognition Decision: Isavuconazonium sulfateAnazaoHealth Corporation. Las Vegas, NV. 483 issued 08/08/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 08/08/2025
Short Title (70 char) AnazaoHealth Corporation. Las Vegas, NV. 483 issued 08/08/2025
FEI Number 3011152407
Firm Name AnazaoHealth Corporation
Record Type 483
State NV
Establishment Type Outsourcing FaCDER Leadership Bios
CDER Leadership BiosMedical Gases — Current Good Manufacturing Practice
Pharmaceutical Quality/Manufacturing Standards (CGMP)The Ambriola Company Issues Recall of Cheese Products Because of Listeria Health Risk
The Ambriola Company is recalling select cheese products after routine testing confirmed the presence of Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy inFDA Adverse Event Reporting System (FAERS) Electronic Submissions
This page provides drug and nonvaccine biological product manufacturers, distributors, packers, outsourcing facilities, and other interested parties with information about FDA Adverse Event Reporting System (FAERS) electronic submissions and instructions on how to electronically submit postmarketing